Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study.
Kathleen ConnollyRichard T GeorgeSami OmarElin MatssonMagnus ÅstrandMagnus AlthageDaniel PettersenEsha MohamedKelly FangJoao Augusto Costa LimaMirjana KujacicHelena ÖdesjöMichelle TurtonPetra JohannessonAnders GabrielsenMarcin UfnalPublished in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique Identifier: NCT04630067.